GlobeNewswire (press release) ... Dr. Schaible's group designed and conducted the SONIC trial in Crohn's disease, a major clinical trial published in the New England Journal of Medicine, demonstrating the superiority of REMICADE® versus a conventional immunomodulator (azathioprine) ... and more »
Wall Street Journal (press release) Teva's and Active Biotech's laquinimod (ABR-215062) is a synthetic, once-daily, orally-administered immunomodulator under investigation for the treatment of RRMS. It is related to, but chemically distinct from, linomide (Roquinimex; Active Biotech); ... and more »
MarketWatch AUBAGIO is an immunomodulator with anti-inflammatory properties. Although the exact mechanism of action for AUBAGIO is not fully understood, it may involve a reduction in the number of activated lymphocytes in the central nervous system (CNS).
4-traders (press release) MGN1703 is based on ® ("double Stem Loop Immunomodulator "), an innovative DNA-based TLR9 agonist developed by MOLOGEN. ® activates the immune system against tumor-associated by targeting various receptors on certain immune cells, primarily ...
Marketwire (press release) Qu Biologics has developed the IBD advisory team to provide guidance and independent oversight of its new Phase 1/2 clinical trial of its investigational drug, QBECO Site Specific Immunomodulator (SSI) for Crohn's disease. The company launched the ... and more »
